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1. Introduction
The main biophysical activity of surfactant is to
reduce drastically the surface tension of the thin
aqueous layer lining the respiratory epithelium of
lungs (for a recent historical perspective see [1]).
This remarkable material has a unique composition
consisting of about 90% lipids, mostly phospholipids,
and 8^10% surfactant-associated proteins. The com-
ponents that are mainly responsible for the surface
properties of surfactant are its phospholipids, surface
tension (Q) being lowered by a mainly lipid ¢lm, tra-
ditionally considered to be monomolecularly thick,
at the air^water interface of the alveoli. Some experi-
ments suggest that this ¢lm might be contiguous with
an underlying multilayer (see chapter by Schu«rch and
colleagues for a more extensive discussion). Dipalmi-
toylphosphatidylcholine (DPPC) is the major surfac-
tant phospholipid, and is also its principal tensoac-
tive compound (agent responsible for attaining very
low surface tension). It is now clear, however, that
speci¢c surfactant-associated proteins are critical to
impart to surfactant phospholipids dynamic proper-
ties necessary for full functionality. The main struc-
tural features of the surfactant proteins that are of
interest to in the interfacial activity of surfactant are
noted in Table 1. The physical properties and the
role of surfactant proteins that will be discussed in
this review will be those that are known to, or likely
to, have direct implication in the events occurring at
or around the air^liquid interface of the respiratory
spaces.
2. Surfactant dynamics outside the cell
Type II pneumocytes package surfactant material
in special organelles known as lamellar bodies, where
the surfactant material is assembled in a series of
densely packed bilayers as seen by electron micro-
scopy. The degree of hydration of these membranes
is probably low, barely enough to hydrate the lipid
head groups fully. SP-A, SP-B and SP-C have been
detected in lamellar bodies [2,3], but SP-A also may
be secreted separately from LB. The closely apposed
bilayers of lamellar bodies are reminiscent of those
found in myelin. As the hydrophobic surfactant-
associated proteins SP-B and SP-C have some struc-
tural and physicochemical properties resembling
those of myelin proteins [4], these two sets of pro-
teins might have similar roles in the close association
of membranes in the two systems.
The surfactant material secreted from type II cells
must transit the aqueous lining layer, or hypophase,
and be e⁄ciently transferred into the interface. Prop-
erly functioning surfactant has an essential property
of adsorbing very rapidly into the interface to form a
tensoactive monolayer. Subsequent to its secretion,
surfactant assumes less densely packed arrangements
which may be forms of surfactant moving into or
away from the air^liquid interface [5]. A unique sur-
factant structure in the hypophase is termed tubular
myelin (TM), an ordered array of tubules of nearly
rectangular cross section [6]. The ‘walls’ of the tu-
bules have bilayer form, and the ‘corners’ are either
intersecting or very closely apposed bilayers with
very high curvature. There is a correlation between
the presence of TM and the ability of surfactant to
adsorb rapidly into the air^liquid interface, leading
to a widely accepted assumption that TM is the im-
mediate precursor of the surface ¢lm. One study has
shown continuity between TM and the air^liquid in-
terface, supporting this assumption [7].
Interfacial adsorption requires the opening of sur-
factant bilayers and the transfer of lipids and pro-
teins into an interfacial layer. It is believed that sur-
factant functions in such a way that only a DPPC-
enriched monolayer is able to produce the very low
surface tensions (Q) required to stabilize the lungs [8].
In consequence, it is thought that the surface ¢lm
undergoes re¢nement to become enriched in DPPC,
either through selective exclusion of non-DPPC ma-
terials or via selective insertion of DPPC (e.g. [8,9]).
Some selectively excluded materials likely can re-
spread into the ¢lm when it is expanded, causing it
to assume many of its original biophysical and rheo-
logical properties. Cyclic monolayer compression
and expansion also causes a continuous loss of ma-
terial from the interface that leads to the cellular
uptake and reprocessing of surfactant lipids and pro-
teins [10].
Surfactant proteins have a key role in its extracel-
lular processes and transformations. Although phos-
pholipids, fundamentally DPPC, provide the neces-
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sary tensoactive function, they alone do not show the
dynamic behavior which is essential to respiratory
function in vivo. The participation of the proteins
will be analyzed in: (a) interfacial monolayer forma-
tion; (b) monolayer re¢ning; (c) stabilization of
monolayers under compression; (d) reformation of
surface ¢lm on expansion; and (e) monolayer turn-
over and recycling.
Table 1
Main structural features of surfactant-associated proteins
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3. Surfactant transit to the interface
To achieve stability on initial opening of the lungs,
surface active material must transfer very rapidly
into the interface. During the breathing cycle, some
replenishment of surface materials is required be-
cause of loss through ¢lm collapse and other exclu-
sion mechanisms along with movement of material
along airways. So pulmonary surfactant must have
the intrinsic capacity to transit rapidly from its three-
dimensional arrangements in the hypophase into the
two-dimensional ¢lm at the surface.
Traditionally, interfacial adsorption has been
measured through its corresponding drop in Q, and
more recently monolayer formation has been fol-
lowed through the visual observation of £uorescent
probes in monolayers of surfactant as they reach the
surface. Samples of surfactant puri¢ed from alveolar
lavages usually adsorb very quickly (e.g. [11]). Such
samples usually have a mixture of the three dimen-
sional physical forms of surfactant including secreted
lamellar bodies (still as densely packed bilayers),
TM, and other loosely packed bilayer forms. The
presence of signi¢cant amounts of TM is correlated
with rapid adsorption of material into the interface,
and TM has been proposed as the immediate precur-
sor of the surface ¢lm. But because other structural
forms are present, unambiguous assignment of a sin-
gle hypophase structure as being the immediate
monolayer precursor has been di⁄cult.
Model systems have been the basis of studies of
the in£uence of surfactant proteins on the formation
of surface ¢lms. Pure DPPC bilayers adsorb very
slowly to the interface. The presence of other phos-
pholipid components of surfactant, mostly unsatu-
rated species, improves somewhat the adsorption
ability of DPPC-containing systems, but adsorption
rates obtained are still below those of natural mate-
rial. Interestingly, dispersed bilayers reconstituted
from material extracted from surfactant by organic
solvents, presumed initially to contain only lipid spe-
cies, adsorbed quite well to form interfacial ¢lms.
These observations led to the discovery of the pres-
ence in those extracts of the hydrophobic surfactant-
associated proteins SP-B and SP-C [12,13]. These
proteins are critical in promoting rapid transit of
bilayer-based surfactant structures from the sub-
phase to the interface, SP-B usually being found to
be more active in this sense than SP-C, and their
e¡ects are additive, not synergistic [14,15]. Inherited
de¢ciencies in these proteins, in particular in SP-B,
are lethal at birth [16]. Various natural or engineered
de¢ciencies in SP-B, however, are accompanied by a
defect in the processing of SP-C so that a critical role
for SP-B alone has not yet been unequivocally estab-
lished.
The major surfactant protein, the collectin SP-A,
does not have a large e¡ect on surfactant adsorption
by itself, but it can improve the adsorptive properties
of systems containing lipids plus hydrophobic pro-
teins [17]. Animals with non-functional SP-A genes
can breathe normally, suggesting that SP-A has a
non-essential role in respiratory mechanics [18]. Ma-
terial obtained from alveolar lavages of those SP-A
de¢cient animals, however, showed reduced adsorp-
tion activity under conditions of limiting concentra-
tion. This fact suggests that SP-A could be important
for interfacial activity under certain limiting circum-
stances. In conditions where phospholipid concentra-
tion could be altered in vivo, as has been described in
several respiratory pathologies, SP-A may play a role
in maintaining surfactant ¢lm homeostasis. These
and other experiments illustrate that the output of
the adsorption experiments in vitro will be dependent
on the conditions selected for the assays, especially
the concentration of tensoactive material in the sub-
phase. Although the concentration of surfactant in
the alveolar £uid is high, expected to be in the order
of 10 Wmol/ml of DPPC [18], subtle di¡erences in
interfacial adsorption can sometimes only be de-
tected when it is assayed under lower concentrations.
This likely ampli¢es the importance of proteins in
pathological studies where surfactant concentration
is reduced or it is otherwise made dysfunctional.
The evidence leads to a model for surface ¢lm
formation which encompasses three di¡erent steps
(see Fig. 1). The ¢rst is the movement of surfactant
aggregates through the hypophase to reach regions
close to the interface. Then, surfactant bilayers must
associate with the interface or with the preexisting
monolayer. Finally, the structure of surfactant bi-
layers must be perturbed and opened to allow for
transfer of molecules to the monolayer. For insertion
into pre-existing monolayers to occur rapidly, espe-
cially when they are at signi¢cant surface pressures,
perturbations of the monolayer packing is also nec-
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essary [19]. Surfactant proteins appear to have key
roles in the three processes: transport, attachment
and transference.
3.1. Transport or movement of surfactant to the
surface
Calculations indicate that the movement of surfac-
tant material into the interface must occur via a con-
certed transfer of assemblages surfactant molecules
into the interface [5,20]. Changes in the environmen-
tal conditions of surfactant complexes when they
reach the hypophase compared with those in lamellar
bodies are likely triggers for transformations leading
to the surface layer formation. An increase in hydra-
tion [3], a change in Ca2 concentration, or an in-
crease in pH [21] have been proposed as possible
inducers of unpacking of lamellar bodies, their trans-
formation into TM, and the transfer of materials
into the interface. These environmental factors could
directly a¡ect the structure of bilayers, or cause
structural changes in surfactant-associated proteins
which in turn may transform the surfactant complex.
SP-A appears to be essential for the formation of
TM (e.g. [22]) which seems to be a form for mole-
cules transiting to the interface. SP-A knock-out
mice, however, can secrete lamellar bodies to form
operative tensoactive material in the subphase, sug-
gesting that alternative mechanisms for interfacial
¢lm formation must exist [18]. Hydrophobic surfac-
tant proteins have been demonstrated to be essential
in the biogenesis of lamellar bodies [23]. Processing
of the SP-C precursor to the mature form of the
protein is coupled with acidi¢cation of the lamellar
body environment. If SP-B and SP-C in£uence pack-
ing of bilayers and monolayers in a pH dependent
manner, the reversion of pH from the lower values of
the lamellar bodies to the near neutral values of the
hypophase after surfactant secretion could drive the
unpacking of the arrays to form the surface.
TM has been reported to be associated with highly
surface active material as a precursor, or a reservoir,
for the surface ¢lm, or both [24]. For reconstitution
of TM in vitro the minimal components required are
DPPC, PG, SP-A, SP-B and Ca2 [22,24]. However,
SP-A knock-out mice show some small TM ¢gures in
their alveolar lavages, suggesting that these struc-
tures could be transiently, but not stably formed in
the absence of SP-A [18]. TM-like structures have
been reconstituted using SP-D instead of SP-A, and
PI as an alternative to PG [25]. PI is selectively rec-
ognized by SP-D, in a calcium-dependent way. We
Fig. 1. Transference of surfactant to the surface.
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do not yet have a model for the molecular assembly
of the singular structure of TM. As noted, TM ap-
pears to have regions at its ‘corners’ where the bi-
layers are under very high curvature strain, or where
there is non-bilayer phase, or both. These regions
could be the initiation sites for concerted transfer
into the interface, a process possibly potentiated by
SP-A. In vitro, SP-A has the ability to aggregate
lipid vesicles in a Ca2-dependent manner [26].
Ca2 also induces SP-A self-aggregation. These proc-
esses, likely associated with TM formation, could
also promote concerted movement of materials to
the surface ¢lms. It has been noted that interfacial
adsorption of lipid^protein samples is enhanced in
the presence of large aggregate forms of surfactant,
likely including but not necessarily restricted to, TM
[27].
The two hydrophobic surfactant proteins, SP-B
and SP-C, independently promote interfacial adsorp-
tion of phospholipids [11,19,28]. SP-B has been
shown to induce lipid vesicle aggregation and fusion
[29,30]. These processes also could enhance the co-
operative movement of material to the surface. The
ability of SP-B to promote transfer of material into
the interface is dependent on the method used to
reconstitute lipid^SP-B samples [30]. Addition of
SP-B to DPPC vesicles caused an instantaneous
and extensive aggregation of vesicles which was as-
sociated with a progressive decay of the interfacial
adsorption ability with time. In contrast, reconstitu-
tion of DPPC/SP-B samples from organic mixtures
produced more stable vesicles with good and long
lived surface adsorption activity. These di¡erent ef-
fects were likely due to alternative locations of and
orientations of the SP-B in the bilayers.
3.2. Surfactant association with the surface and
bilayer^monolayer contacts
There is evidence suggesting that a substantial
amount of surfactant is associated with the air^liquid
interface before it is transferred to the monolayer
[31]. The surface ¢lm could then be considered as a
multilayer rather than as a pure single monolayer
[32]. In such a surface structure there may be mono-
layer^bilayer contacts promoted by surfactant pro-
teins. SP-B and SP-C located in monolayers are
able to promote interfacial insertion of phospholipids
from liposomes in the hypophase [19]. The proteins
might act as catalysts or transporters themselves or
they might promote concerted lipid transfer by caus-
ing close monolayer^bilayer adhesion and conse-
quently reduce the energy barrier for direct transfer.
The positive charges of SP-B [33] and SP-C [34]
are important for their ability to promote interfacial
adsorption of phospholipids. Surfactant phospha-
tidylglycerol (PG) could mediate bilayer^bilayer or
bilayer^monolayer contacts via electrostatic interac-
tions with the cationic surfactant proteins [19]. The
importance of acylation of SP-C for its interfacial
properties is not fully understood. The absence of
palmitates did not substantially a¡ect SP-C-
promoted adsorption rates [35]. On the other hand,
the presence of acyl chains on SP-C has been found
to improve monolayer stability and lipid respreading
upon expansion of monolayers containing SP-C
[36].
The participation of SP-A in the accumulation of
tensoactive material at the surface has been also
demonstrated [37]. The fact that both SP-A [26]
and SP-B [29,30] induce aggregation of lipid bilayers
in vitro supports the concept that both proteins
could mediate interbilayer as well as bilayer^mono-
layer contacts.
3.3. Transfer of surfactant into the air^liquid interface
All the three-dimensional structures of surfactant
in the aqueous subphase are based on phospholipid
bilayers. These bilayers must be somehow disrupted
for the phospholipid molecules to be moved into the
interface. Studies have shown that hydrophobic sur-
factant proteins SP-B and SP-C perturb packing of
phospholipid molecules in model monolayers and bi-
layers [19,27,38,39]. Both SP-B and SP-C, for in-
stance, increase the apparent polarity of the surface
of DPPC bilayers, suggesting a certain relaxation of
the membrane packing in the presence of the proteins
[39], which in turn would facilitate phospholipid ad-
sorption. The fusogenic properties of SP-B [29] sug-
gest a mechanistic basis for its involvement in the
transformations required to convert the lamellar
bodies into TM, and bilayers into monolayers. In
certain regions of TM, or in bilayer^monolayer tran-
sition intermediates, phospholipids could temporarily
acquire non-lamellar phases, particularly the HII hex-
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agonal phase. The presence of HII-promoting lipids
enhances the adsorptive properties of surfactant [40].
There has been no testing to date to determine if at
physiological concentrations SP-B or SP-C can in-
duce such lipid polymorphism. Perturbation of bi-
layers by SP-B is usually thought to occur through
the interaction of cationic amphipathic K-helical seg-
ments of the protein with the surface of surfactant
bilayers [33]. The good tensoactive properties of
some synthetic peptides mimicking SP-B amphi-
pathic regions would be consistent with these ideas
(see also Table 2). Electrostatic interactions are prob-
ably modulators of SP-B/phospholipid interactions in
some cases, as some selectivity of SP-B for interac-
tion with PG has been reported [39,41,42]. The na-
ture and extent of the perturbations induced by SP-B
in surfactant bilayers that could be of relevance for
its interfacial activity remains under investigation.
Both deeper [33,39,43] and shallower [43,44] e¡ects
of SP-B in phospholipid acyl chain mobility and dy-
namics have been described. One reason for these
discrepancies could be that the physical structure of
SP-B/phospholipid complexes is dependent on the
method of reconstitution [30]. Although homozygous
mutations with an absence of SP-B produce irrever-
sible and lethal respiratory failure at birth [16], the
absence of SP-B is coincident with aberrant process-
ing of SP-C from its precursor form. This fact could
mean that respiratory failure in SP-B defective ani-
mals could be at least partially caused by lack of an
operative, mature SP-C.
SP-C has been also proposed to participate in the
transfer of phospholipid molecules to the interfacial
monolayer [19]. This protein also perturbs the acyl
chain packing of phospholipid bilayers [39] and
monolayers [19,45] and this probably facilitates the
exchange of molecules between both structures. With
increasing surface pressure (Z), the hydrophobic K-
helix of SP-C reorients in monolayers [46], suggesting
that it could act as a ‘lever’ to raise the phospholipid
acyl chains in the interface and therefore facilitate
insertion of more lipid molecules. The insertion of
the palmitates at cysteines 5 and 6 of SP-C into the
interface could act as a bridge between bilayers and
monolayers. Conformational changes in SP-C at the
N-terminal segment then could aid in transferring
patches of bilayers to the monolayer in a concerted
manner. Direct evidence for this mechanism is
needed, as the importance of palmitates in SP-C
for its interfacial properties remains ambiguous.
(See chapter by Johansson for additional informa-
tion on SP-C structural modi¢cations.)
In summary, SP-B, and probably SP-C, are instru-
mental in the ¢nal transfer of surfactant molecules to
the interface. SP-A could facilitate the prior steps of
moving the tensoactive material to the surface and
maintaining the interfacial reservoir. The fact that
SP-B and SP-C promote adsorption by themselves
Fig. 2. Re¢ning of surfactant monolayer under compression.
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while SP-A improves adsorption of bilayers when
they contain hydrophobic surfactant proteins, would
be consistent with this view.
4. Re¢ning surfactant monolayers
For the lung to be stable at low surface tension,
the material in the monolayer must sustain very high
Z over a moderately long time [47]. Of the compo-
nents of surfactant, only a monolayer of DPPC can
meet this requirement under physiological condi-
tions. For this reason it is generally thought that
the surfactant monolayer must undergo a selective
enrichment in DPPC during the breathing cycle.
This re¢ning could proceed either through processes
of selective exclusion of non-DPPC materials or via
selective insertion of new DPPC molecules (see Fig.
2). There is evidence supporting the existence of both
mechanisms and, in both cases, surfactant-associated
proteins are thought to play roles in de¢ning the
phospholipid species destined to remain in the inter-
face at the highest Z.
4.1. Selective squeeze-out
Only a monolayer rich in saturated phosphatidyl-
choline (PC) and at a temperature below its intrinsic
rigid to £uid melting point can be compressed to Z
higher than 50 mN/m [8]. The temperature of gel-to-
£uid phase transition for DPPC in bilayers is around
41‡C (or a few degrees higher under high Z) so
DPPC monolayers at 37‡C are rigid enough to be
compressed to high Z without collapse. They enter
a metastable state which will slowly relax to the equi-
librium pressure of 45^50 mN/m. Surfactant in the
hypophase contains much more than DPPC, the oth-
er components having an e¡ect which would increase
the £uidity of monolayers and lead to collapse at
lower Z or higher Q (e.g. [28]). Assuming that the
initial composition of the surface ¢lm re£ects that
of surfactant in the hypophase, it has been consid-
ered that the surface ¢lm must undergo selective
squeeze-out of non-DPPC components during com-
pression to achieve the necessary DPPC-rich state
capable of sustaining high Z (e.g. [8]). The behavior
of ¢lms spread from solvent has often been analyzed
with respect to the phenomena of squeeze-out. Epi-
£uorescence microscopy observations have con¢rmed
that spread monolayers have similar features to those
formed by adsorption of lipid^protein vesicles (the
latter process being equivalent to spontaneous mono-
layer formation in vivo) [48]. Compression isotherms
of surfactant monolayers in vitro show plateaus that
are consistent with the existence of a squeeze-out
process occurring at pressures near the collapse pres-
sures of monolayers of the non-DPPC components.
It is possible also that those plateaus are associated
with reorientation of compounds, such as proteins or
with a redistribution of domains of lipids within the
surface.
Physical studies on model lipid mixtures in surface
balances have shown that at least part of the inter-
facial re¢ning via squeeze-out is likely associated
with intrinsic properties of the lipids and their sur-
face distribution (e.g. [9]). While DPPC-rich domains
remain in the interface, other species which collapse
at lower Z form phases that somehow leave the sur-
face. Surfactant proteins may optimize the process.
Hydrophobic proteins SP-B and SP-C are strongly
associated with surfactant lipids in bilayers and
they are also capable of being transferred to the in-
terface. Isotherms of lipid^protein monolayers con-
taining SP-B and SP-C show discontinuities and pla-
teaus consistent with exclusion of proteins and lipids
under compression [49^51]. SP-B is partially ex-
cluded from monolayers of either DPPC or DPPG
at Z around 40^45 mN/m, without carrying signi¢-
cant amounts of lipid out of the monolayer with it
[48,49]. At low Z, SP-B may modify lipid packing in
the monolayer, but at higher pressures some of it
appears to remain associated with, but not perturb-
ing, the monolayers [50,51]. SP-B can also interact
with PC bilayers in two ways, with di¡erent e¡ects
on surface activity and lipid acyl chain packing and
mobility [30]. Selective interaction of SP-B with cer-
tain lipid species such as PG [39,44] might be con-
ducive to lipid segregation in patches, but since the
removal of SP-B during compression is not accom-
panied by either anionic or zwitterionic lipid, no spe-
cial removal of lipid, at least saturated lipid, is likely
to occur in the presence of SP-B alone [50].
Compression isotherms of monolayers containing
SP-C and DPPC or DPPG or both phospholipids
show that there is a partial exclusion of SP-C at Z
above that for exclusion of SP-B [50]. In contrast to
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the case of SP-B, the excluded SP-C molecules are
each accompanied by about 7^10 lipid molecules
[45,50]. Exclusion of SP-C during compression would
then drive expulsion of lipids. In the case studied
there was no di¡erence in amount of lipid excluded
from either DPPC or DPPG monolayers, so that
selective exclusion cannot be implied from these
data [45,50]. Additional studies with unsaturated lip-
ids would be worthwhile to test for its potential to
promote their selective exclusion.
As with SP-B, under some conditions SP-C has
shown certain inclination for interaction with acidic
phospholipids in bilayers and monolayers [34,39].
Also, SP-C resides in £uid domains of bilayers [52]
and monolayers [53] whenever there is a coexistence
of £uid and rigid regions. The exclusion of SP-C
from DPPC gel phase in bilayers might be explained
as a result of the mismatch between the thickness of
such bilayers and the length of the transmembrane K-
helix of SP-C [54]. The preference of SP-C for ex-
panded £uid regions of the monolayer suggests that
SP-C could potentiate certain non-compressible £uid
phase regions for exclusion.
In the absence of calcium, monolayers, containing
SP-B and SP-C simultaneously, produced isotherms
with two di¡erent squeeze-out plateaus at 45 and
55 mN/m, respectively [51]. This is consistent with
independent exclusion of the proteins from the
monolayer in sequential steps during compression.
In the presence of calcium, however, monolayers
containing SP-B and SP-C showed only one exclu-
sion plateau at the pressure of SP-C. This suggests
that calcium either prevented the squeeze-out of
SP-B, or it produced association of SP-B and SP-C
leading to exclusion of the combined protein com-
plex plus lipids.
4.2. Selective insertion of DPPC into the monolayer
It has been proposed that selective insertion of
DPPC molecules is a means to enrich monolayers
in this component. Using a captive bubble surfac-
tometer containing suspensions of surfactant, it was
found that surface tensions consistent with a nearly
pure DPPC-¢lm were reached at unexpectedly low
compression rates [55], and that the extent of surface
compression necessary to reach very low Q expected
of ¢lms enriched in DPPC was substantially less than
that predicted based upon removal of non-DPPC
materials during compression. The implicit sugges-
tion was therefore that mechanisms of selective in-
sertion of DPPC may be contributing to its enrich-
ment in the interface, and that this mechanism
involved action of SP-A [37,55]. SP-A preferentially
interacts with DPPC in comparison to other lipids
[56,57]. SP-A interacts with the boundaries between
condensed and £uid regions in DPPC monolayers
[58] and it binds best to bilayers containing high
amounts of gel^£uid boundaries [59]. It has been
suggested that SP-A can also form bridges between
the interfacial monolayer and subphase bilayers, con-
tributing to the establishment of a surfactant surface
reservoir [37]. Interaction of SP-A with DPPC-rich
domains in the bilayers and monolayers could then
lead to the approach to the interface of ‘DPPC res-
ervoirs’ in the sub¢lms poising the system for con-
certed transfer. The ¢nal transfer of DPPC molecules
could require the cooperation of other surfactant
proteins. This would also explain why SP-A by itself
does not enhance the adsorptive properties of phos-
pholipids but further improves adsorption in samples
containing surfactant hydrophobic proteins [16]. Re-
cent experiments show that SP-B also associates with
the boundaries of condensed domains of DPPC
monolayers when SP-A is added, suggesting SP-A/
SP-B interaction at the interface (K. Nag, J. Pe¤rez-
Gil, K.M.W. Keough, unpublished results). A model
could then be proposed in which SP-B and, maybe
SP-C, would have the activity of catalyzing phospho-
lipid insertion into the interface but in a rather un-
selective way, while SP-A could direct action onto
DPPC-enriched material. In keeping this view, sur-
factant of SP-A knock-out mice would be defective
in selective DPPC-insertion mechanisms, and that
de¢ciency could be the reason that surfactant from
those animals can only reach higher minimal Q under
compression in comparison to surfactant from nor-
mal animals [18].
5. The interfacial monolayer at high surface pressures
Not all the respiratory spaces move in synchrony
during the breathing cycle, and there exist regions
which are in di¡erent states of expansion or contrac-
tion at any time. In order to maintain the operativity
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of the smaller alveoli, Q must remain relatively low
for some period of time [47]. In vitro, the surface
tension of compressed surfactant ¢lms is stable
over periods of minutes, especially when Q is very
low, further supporting the necessity for a DPPC-
enriched ¢lm in vivo and the existence of mecha-
nisms to produce it [60]. On the other hand, the
physical properties of the quasi-solid surfactant ¢lm
in conditions of sustained compression are modu-
lated by the presence of small, but signi¢cant,
amounts of other non-DPPC components. Some hy-
drophobic surfactant proteins, SP-B or SP-C or
both, are retained in the interface when the mono-
layer is practically all condensed at high Z [48,53].
The proteins probably supply special viscoelastic fea-
tures to the ¢lm that could be of relevance to the
maintenance of airspaces at low tidal volumes [61].
SP-B, for instance, has been suggested to reduce in-
terfacial surface tension by increasing the lateral
stability of the surface layer [33]. SP-C, on the other
hand, has been shown to provide £exibility to con-
densed DPPC monolayers which then show less hys-
teretic behavior when they are subjected to recurrent
compression^expansion cycles [11,61]. Direct obser-
vation of £uorescently labeled SP-B or SP-C in
monolayers shows that at lower pressures both pro-
teins are associated with liquid^expanded regions
[53,54,62]. Both proteins modify the packing of
DPPC or DPPG monolayers in such a way that
more, smaller condensed domains are produced dur-
ing the compression of the monolayer compared to
those in ¢lms in the absence of protein. In the pres-
ence of the protein, condensed phase regions then
can be more homogeneously distributed in the mono-
layer, which could be the basis of some of the ¢lm
dynamics and ¢lm £exibility at high pressures.
Monolayers made from lipid extracts of surfactant
(which contain SP-B and SP-C), and doped with a
£uorescent probe, also show segregation of con-
densed domains upon compression [63,64]. At high
pressures the monolayer seems to be composed of a
¢ne lattice of very small rigid domains embedded in a
¢nely divided matrix of more £uid-like probe-con-
taining phospholipids. Such a ¢lm could have simul-
taneously properties of low compressibility and
metastability, but also the advantages of a £exible
¢lm to work under the dynamic conditions imposed
by the lung [58,65]. Such a ¢nely divided network of
condensed and £uid domains produced by the pro-
tein in the monolayer is reminiscent of what could be
considered a ‘two-dimensional alloy’ potentially hav-
ing unique physical properties.
It should be considered that the ¢lms at high pres-
sure might represent a system di¡erent from the sim-
ply conceived, DPPC-rich arrangement described
above. Since, for example, squeeze-out of lipids in
the presence of proteins such as SP-C may not be
highly selective (see above), perhaps the surfactant
Fig. 3. Respreading of surfactant ¢lm upon expansion.
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¢lm composition may not be substantially altered
from the gross composition, but the presence of hy-
drophobic proteins at high pressure (see above) may
confer some additional stability to the ¢lms over
those of mixed lipid ¢lms alone.
6. Renewal of surfactant ¢lms upon expansion
It can be anticipated that re-expansion of an inter-
face containing a ¢lm and a collapsed phase that are
rich in DPPC it would lead to incomplete respread-
ing and insu⁄cient re¢lling of the surface available.
The result is that during ¢lm expansion there is the
transient production of ‘empty’ surface spaces. Re-
plenishment of the surface can happen via relaxation
of compressed components of the ¢lm, adsorption
from subphase structures as discussed above, and
respreading of both collapse phases and selectively
excluded phases (Fig. 3). The composition of the
latter two forms are not likely equivalent nor will
either have the general composition of surfactant as
it is secreted from cells. Isotherms of monolayers
formed from whole surfactant show less hysteresis
on compression^expansion cycles, consistent with
more rapid replenishment, than those prepared
from DPPC or other pure phospholipid systems
[11]. Monolayers prepared from organic extracts of
surfactant behave more like the whole natural prep-
arations in this respect, indicating an important role
of the hydrophobic surfactant proteins in respread-
ing the lipid into the monolayer. That portion of
SP-B or SP-C which appears to remain in the col-
lapse phases, and also in the selectively excluded
phase, can enhance the rate of redistribution of ma-
terial in the interface upon expansion [66]. The mod-
ulation of the rheological properties of lipid ¢lms by
SP-C [61] is also consistent with its ability to pro-
mote respreading of lipids. Epi£uorescence micro-
scopy of monolayers and scanning force microscopy
on Langmuir-Blodgett ¢lms con¢rmed that the ap-
pearance of ¢lms after compression and re-expansion
to low Z very closely resembles that of ¢lms during
their initial compression stages [45,53,62]. The exclu-
sion of the protein occurring during compression can
be reversed on expansion since the material excluded
from the interface seems to be closely associated with
the monolayer [45,53,62].
The hydrophobic proteins associated with the ex-
cluded phases could help form associated multilayers
at the surface [51] which might have signi¢cance not
only in surface replenishment, but also in surface
stability.
7. Turnover of surfactant monolayers
Studies in vitro have shown that some of the ma-
terial excluded from the monolayer permanently
leaves the surface, to form small subphase structures
that have reduced tensoactive properties [67]. This
continuous removal of surface material is responsible
for the existence, in the alveolar lavages, of fractions
of surfactant di¡ering in structure (density, compo-
sition, lipid/protein ratio) and function (surface ac-
tivity) [68]. The processes of conversion of surfactant
into the di¡erent subfractions have been studied in
vitro by ‘cycling’ experiments [67]. In this approach,
surfactant preparations are subjected to rotational
agitation in such a way that there is a periodic oscil-
lation in the area of the air^liquid interface. Cycling
of such samples produces a conversion of large, sur-
face-active, surfactant aggregates into smaller, non-
active forms. Conversion of natural samples isolated
from alveolar lavages is dependent on the activity of
an enzyme termed ‘convertase’. Initially it was
thought that the enzyme was a protease, the main
substrate of which seemed to be SP-B. Recent studies
on the ‘convertase’ indicate, however, that it is most
likely a lipase with an unknown substrate [69]. SP-A
has been demonstrated to contribute to the mainte-
nance of large surfactant aggregates [70]. The pres-
ence of SP-A and Ca2, two of the elements neces-
sary to form TM and to produce extensive surfactant
aggregation, inhibits surfactant ‘conversion’ during
cycling.
In vivo, small surfactant particles coming from
interfacial conversion are either phagocytized by al-
veolar macrophages or subjected to reuptake by type
II pneumocytes for reprocessing, adding to surfac-
tant being synthesized de novo [10].
8. Tensoactive peptides
Several attempts have been made to design simple
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peptides able to mimic the main e¡ects of surfactant
proteins on the tensoactive properties of phospho-
lipids. Such peptides could provide useful insight
into structure and mechanism, and also become the
bases for therapeutic surfactant preparation.
Table 2 summarizes some of the more interesting
peptides. Potential surface active polypeptides can be
classi¢ed in two main groups. Some have been de-
signed as amphipathic helices modelling putative am-
phipathic segments of SP-B. The utility of hydropho-
bic transmembrane-like helical peptides resembling
the structure of SP-C has also been explored. Most
of those peptides provided good adsorption and
spreading properties to bilayers composed of DPPC
and PG. This is consistent with the proposed role of
the hydrophobic surfactant proteins in perturbing
the packing of phospholipid molecules and facilitat-
ing bilayer^monolayer transitions and respreading
from collapse phases. Particularly e⁄cient peptides
were those matching the N-terminal and C-terminal
sequences of SP-B and peptides composed of the
short N-terminal sequence of SP-C attached to a
generic, highly hydrophobic, K-helix of the same
length as in SP-C. Interestingly, hydrophobic pepti-
des with a transmembrane-like portion, seem to be
more e⁄cient than amphipathic, periphery seeking
versions. In addition to the location of a model pep-
tide in bilayers or monolayers, helicity and funda-
mentally hydrophobicity seem to be the critical fac-
tors in inducing good tensoactive properties.
Considerable work is still needed to understand the
role of speci¢c structural determinants of surfactant
proteins.
9. Summary
Pulmonary surfactant proteins play a key role in
modulating the interfacial properties of surfactant
phospholipids, leading to a complex and dynamic
cycle of material at the air^liquid interface of alveoli.
Hydrophobic surfactant proteins, SP-B and SP-C,
modulate arrangements of surfactant phospholipids
in bilayers and monolayers, and promote transfer of
tensoactive molecules between di¡erent surfactant
structural assemblies. These properties are essential
for rapid adsorption of surfactant into the air^liquid
interface, and respreading of surfactant from collapse
phases during expansion, and, consequently, the
maintenance of an interfacial surfactant complex
that is stable during respiratory dynamics. SP-C
may impart special physical properties to surfactant
¢lms. Compressed SP-C-containing monolayers seem
to be at the same time solid enough to stabilize the
respiratory surface, but £exible enough to elastically
recuperate when expanded. SP-A appears to have a
cooperative participation in the interfacial properties
of surfactant containing SP-B and SP-C. Although
the essential role of SP-A in the direct tensoactive
properties of surfactant remains unresolved, it is es-
sential to form TM, leading to the view that it can
have an important role in monolayer formation also.
SP-D, like SP-A, may have more important roles in
host-defense mechanisms, but under some condi-
tions, such as in surfactant containing high amounts
of phosphatidylinositol, it may play a role in the
tensoactive function of surfactant.
While lipids, especially DPPC, are the main com-
ponents of surfactant responsible for lowering of sur-
face tension in the lung, the surfactant proteins, par-
ticularly SP-B and SP-C, are crucial in providing it
with full physiological and physical activity.
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